Additional colocalisation was identified between the ratio of histidine-to-glutamine, glutamine, Alzheimer’s disease and SPRYD4 gene expression on chromosome 12. The gene discussed is SPRYD4; the disease is early-onset autosomal dominant Alzheimer disease.